{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:29:04Z","timestamp":1780457344343,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Intramural Research Program"},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EY000546"],"award-info":[{"award-number":["EY000546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ophtha.2019.06.023","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T11:46:27Z","timestamp":1561549587000},"page":"1647-1656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies"],"prefix":"10.1016","volume":"126","author":[{"given":"Tiarnan D.","family":"Keenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci E.","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/eye.2015.288","article-title":"Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013","volume":"30","author":"Quartilho","year":"2016","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib3","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A\u00a0large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ophtha.2019.06.023_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","article-title":"Age-related macular degeneration: genetics and biology coming together","volume":"15","author":"Fritsche","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"10.1016\/j.ophtha.2019.06.023_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"9678","key":"10.1016\/j.ophtha.2019.06.023_bib8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2019.06.023_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2017.03.046","article-title":"Antithrombotic agents for secondary prevention after acute coronary syndromes: a systematic review and network meta-analysis","volume":"241","author":"Fanaroff","year":"2017","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/STROKEAHA.114.008422","article-title":"Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials","volume":"46","author":"Kwok","year":"2015","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ophtha.2019.06.023_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1472-8206.2009.00769.x","article-title":"Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis","volume":"24","author":"Lievre","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.2014.889680","article-title":"Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?","volume":"13","author":"Christen","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib14","first-page":"691","article-title":"Does aspirin increase the risk of age-related macular degeneration?","volume":"13","author":"Chong","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib15","first-page":"687","article-title":"Aspirin and age-related macular degeneration: positives versus negatives","volume":"13","author":"Nowak","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2013.04.023","article-title":"Regular aspirin use and risk of age-related macular degeneration","volume":"156","author":"Sobrin","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"17","key":"10.1016\/j.ophtha.2019.06.023_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198804283181710","article-title":"Macular hemorrhage in the aging eye: the effects of anticoagulants","volume":"318","author":"Kingham","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archopht.122.4.575","article-title":"Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration","volume":"122","author":"DeAngelis","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib19","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ophtha.2006.09.018","article-title":"A\u00a0case-control study of drug risk factors for age-related macular degeneration","volume":"114","author":"Douglas","year":"2007","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2019.06.023_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/eye.2010.8","article-title":"Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study","volume":"24","author":"Rudnicka","year":"2010","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.023_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0161-6420(86)33702-3","article-title":"Risk factors in age-related maculopathy complicated by choroidal neovascularization","volume":"93","author":"Blumenkranz","year":"1986","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bjophthalmol-2012-302253","article-title":"Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study","volume":"97","author":"Cheung","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.023_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ophtha.2011.06.025","article-title":"Associations between aspirin use and aging macula disorder: the European Eye Study","volume":"119","author":"de Jong","year":"2012","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.ophtha.2019.06.023_bib24","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/jama.2012.65406","article-title":"Long-term use of aspirin and age-related macular degeneration","volume":"308","author":"Klein","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamainternmed.2013.1583","article-title":"The association of aspirin use with age-related macular degeneration","volume":"173","author":"Liew","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.ophtha.2019.06.023_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.119.8.1143","article-title":"Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians","volume":"119","author":"Christen","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2019.06.023_bib27","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ophtha.2009.05.031","article-title":"Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women","volume":"116","author":"Christen","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2019.06.023_bib28","doi-asserted-by":"crossref","first-page":"e58821","DOI":"10.1371\/journal.pone.0058821","article-title":"Aspirin use and risk of age-related macular degeneration: a meta-analysis","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib29","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1167\/iovs.13-13206","article-title":"Association between aspirin use and age-related macular degeneration: a meta-analysis","volume":"55","author":"Ye","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.023_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcjo.2013.07.016","article-title":"Aspirin use and early age-related macular degeneration: a meta-analysis","volume":"49","author":"Kahawita","year":"2014","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jcpt.12241","article-title":"Is aspirin use associated with age-related macular degeneration? A meta-analysis","volume":"40","author":"Li","year":"2015","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.023_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amepre.2014.11.005","article-title":"Aspirin use among adults in the U.S.: results of a national survey","volume":"48","author":"Williams","year":"2015","journal-title":"Am J Prev Med"},{"issue":"9","key":"10.1016\/j.ophtha.2019.06.023_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/IAE.0000000000001475","article-title":"Macular Degeneration and Aspirin Use","volume":"37","author":"Small","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2019.06.023_bib34","series-title":"Daily aspirin tied to risk of vision loss [press release]","year":"2011"},{"key":"10.1016\/j.ophtha.2019.06.023_bib35","series-title":"Regular aspirin use tied to age-related vision loss [press release]","year":"2013"},{"key":"10.1016\/j.ophtha.2019.06.023_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4614-3209-8_36","article-title":"Is age-related macular degeneration a microvascular disease?","volume":"801","author":"Mullins","year":"2014","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.ophtha.2019.06.023_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molmed.2016.06.009","article-title":"A\u00a0revised hemodynamic theory of age-related macular degeneration","volume":"22","author":"Gelfand","year":"2016","journal-title":"Trends Mol Med"},{"issue":"16","key":"10.1016\/j.ophtha.2019.06.023_bib38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ophtha.2019.06.023_bib39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ophtha.2019.06.023_bib40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","article-title":"The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1","volume":"20","year":"1999","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.ophtha.2019.06.023_bib42","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.06.023_bib43","first-page":"67","article-title":"A\u00a0comparison of propensity score and linear regression analysis of complex survey data","volume":"4","author":"Zanutto","year":"2006","journal-title":"J\u00a0Data Sci"},{"issue":"12","key":"10.1016\/j.ophtha.2019.06.023_bib44","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.ophtha.2015.08.028","article-title":"The association of statin use with age-related macular degeneration progression: the Age-Related Eye Disease Study 2 report number 9","volume":"122","author":"Al-Holou","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.023_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ophtha.2015.10.040","article-title":"The association of statin use with cataract progression and cataract surgery: the AREDS2 report number 8","volume":"123","author":"Group","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.06.023_bib46","series-title":"Reducing bias in a propensity score matched-pair sample using greedy matching techniques. SAS Institute Inc, Cary, NC. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference","author":"Parsons","year":"2001"},{"key":"10.1016\/j.ophtha.2019.06.023_bib47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmpb.2014.11.009","article-title":"PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression","volume":"118","author":"Kohl","year":"2015","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ophtha.2019.06.023_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1076\/opep.6.2.125.1558","article-title":"Do age-related macular degeneration and cardiovascular disease share common antecedents?","volume":"6","author":"Snow","year":"1999","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.023_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/resp.12312","article-title":"Introduction to propensity scores","volume":"19","author":"Williamson","year":"2014","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.ophtha.2019.06.023_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ophtha.2019.06.023_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.conctc.2017.03.005","article-title":"Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: rationale and study design of the ASPREE-AMD study","volume":"6","author":"Robman","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ophtha.2018.09.014","article-title":"Long-term regular use of low-dose aspirin and neovascular age-related macular degeneration: National Sample Cohort 2010\u20132015","volume":"126","author":"Rim","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ophtha.2015.09.046","article-title":"Association between antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Ying","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.023_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1534\/genetics.116.196998","article-title":"Bivariate analysis of age-related macular degeneration progression using genetic risk scores","volume":"206","author":"Ding","year":"2017","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.023_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2004.03.008","article-title":"Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System","volume":"27","author":"Kim","year":"2004","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.023_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amepre.2007.01.010","article-title":"Aspirin use among\u00a0adults aged 40 and older in the United States: results of\u00a0a national survey","volume":"32","author":"Pignone","year":"2007","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.023_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.023_bib60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201930819X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201930819X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:59Z","timestamp":1758982079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164201930819X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S016164201930819X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.023","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}